Jonathan J Darrow (Jonathan Darrow)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Silver Nanoparticles

Top Venues

Journal of the American Geriatrics Society

Open forum infectious diseases

Nature biotechnology

Journal of general internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Leah Zoe Gibson Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan J Darrow, Aaron S Kesselheim
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?" Journal of the American Geriatrics Society 72 (9) (2024)
Jonathan J Darrow, Victor Van de Wiele, Beatrice Brown, Aaron S Kesselheim
The prevalence of post-NDA drug patents and their relationship to the timing of generic approval. Nature biotechnology 42 (9) (2024)
Leah Zoe Gibson Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan J Darrow, Aaron S Kesselheim
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?" Journal of the American Geriatrics Society (2024)
Danielle M Pacia, Beatrice L Brown, Timo Minssen, Jonathan J Darrow
CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations. Journal of law and the biosciences 11 (1) (2024)
Leah Zoe Gibson Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan J Darrow, Aaron S Kesselheim
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?" Journal of the American Geriatrics Society 72 (9) (2024)
Leigh K Sharpless, Aaron S Kesselheim, Serena Laura Orr, Jonathan J Darrow
Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications. Neurology (2023)
Jonathan J Darrow
Two views of cancer medicines: Imagery versus evidence. Health marketing quarterly (2022)
Jonathan J Darrow, Sanket S Dhruva, Rita F Redberg
Changing FDA Approval Standards: Ethical Implications for Patient Consent. Journal of general internal medicine 36 (10) (2021)
Jonathan J Darrow
Government Pharmaceutical Development to Address High Prices: Challenges Ahead. Therapeutic innovation & regulatory science 55 (5) (2021)
Jonathan J Darrow, Monica Sharma, Mansa Shroff, Anita Katharina Wagner
Efficacy and costs of spinal muscular atrophy drugs. Science translational medicine 12 (569) (2021)
Jonathan J Darrow, Aaron S Kesselheim
Incentivizing Antibiotic Development: Why Isn't the Generating Antibiotic Incentives Now (GAIN) Act Working? Open forum infectious diseases 7 (1) (2020)
Jonathan J Darrow, Reed F Beall, Aaron S Kesselheim
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents. Applied health economics and health policy 17 (1) (2020)
John H Rex, Holly Fernandez Lynch, Ivan Glenn Cohen, Jonathan J Darrow, Kevin Outterson
Designing development programs for non-traditional antibacterial agents. Nature communications 10 (1) (2019)